CLINICAL_TRIALS
trial_result
· 2023-09-21
Clinical Trial Update: Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments. [Phase 3]
Summary
Phase 3 trial update for atogepant in patients with episodic migraine who failed previous oral prophylactics; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Episodic Migraine | Phase 3 | Status: COMPLETED | Results posted: 2023-09-21